Pharma & Biotech

Biotechnology firm Ocugen faces a pivotal moment this Wednesday, November 5, 2025, as it prepares to disclose its third-quarter financial...

Eli Lilly & Company appears poised to transform the competitive landscape of the multi-billion dollar weight-loss medication sector through a...

Market analysts are turning increasingly bullish on HealthEquity as the company benefits from favorable regulatory developments and strategic product launches....

Investors are closely monitoring Coherus BioSciences as the biotechnology firm prepares to release its third-quarter 2025 financial results after market...

Shares of Balchem Corporation demonstrated minimal movement in recent trading, holding steady despite the release of groundbreaking clinical data for...

The biotechnology sector is demonstrating its notoriously unforgiving nature, with ImmunityBio caught in a severe downturn. As the company's stock...

NuCana plc's stock continues to experience significant downward pressure, with shares declining 1.75% during the latest trading session to close...

Intellia Therapeutics faces a pivotal juncture as the market anticipates its upcoming quarterly earnings release. The biotech firm's stock remains...

IO Biotech's stock continues its downward trajectory, with Monday's 12 percent plunge signaling further volatility ahead. The company confronts a...

All attention turns to Tandem Diabetes Care as the medical device company prepares to release its third-quarter 2025 financial results...